NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

幹細胞療法的全球市場:各類型,各最終用途,各細胞來源,各終端用戶,各地區的分析,佔有率,趨勢,市場規模(2020年∼2026年)

Stem Cell Therapy Market, by Types, by Application, by Cell Source, by End-Use, and by Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026

出版商 AnalystView Market Insights 商品編碼 930161
出版日期 內容資訊 英文 206 Pages
商品交期: 2-3個工作天內
價格
幹細胞療法的全球市場:各類型,各最終用途,各細胞來源,各終端用戶,各地區的分析,佔有率,趨勢,市場規模(2020年∼2026年) Stem Cell Therapy Market, by Types, by Application, by Cell Source, by End-Use, and by Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026
出版日期: 2020年03月01日內容資訊: 英文 206 Pages
簡介

幹細胞療法,是透過組織的修復與再生改善內臟器官功能的治療方法,在糖尿病、脊髓損傷、帕金森氏症、阿茲海默症、癌症、心臟病、骨關節炎等各種疾病的治療中採用,也進行中樞神經系統疾病,眼科疾病,創傷和損傷,肌肉骨骼系統疾病,代謝障礙,週期性嘔吐症候群,免疫系障礙等的治療應用的研究開發。

本報告提供全球幹細胞療法市場調查,產業與市場的狀況,各類型,各最終用途,各細胞來源,各終端用戶,各地區的分析,主要供應商分析等資訊。

目錄

第1章 市場概要

  • 調查範圍
  • 前提條件與調查方法

第2章 摘要整理

第3章 市場主要趨勢

  • 成長促進因素
    • 成長促進因素的影響分析
  • 成長阻礙因素
    • 成長阻礙因素的影響分析
  • 市場機會
  • 市場未來趨勢

第4章 產業分析

  • 波特的五力分析
  • 行銷策略分析
  • 成長預定的製圖
  • 法律規範分析

第5章 市場情勢

  • 市場佔有率分析
  • 主要的創新者
  • 各主要製造商的明細資料
    • 現有企業分析
    • 新興企業分析

第6章 市場分析:各類型

  • 概要
    • 市場區隔佔有率分析:各類型(2019年和2026年)
  • 自我幹細胞療法
  • 同類幹細胞療法

第7章 市場分析:各最終用途

  • 概要
    • 市場區隔佔有率分析:各最終用途(2019年和2026年)
  • 眼科疾病
  • 創傷,損傷
  • 中樞神經系統疾病
  • 心血管疾病
  • 代謝異常
  • 腫瘤
  • 肌肉骨骼系統疾病
  • 免疫系障礙

第8章 市場分析:各細胞來源

  • 概要
    • 市場區隔佔有率分析:各細胞來源(2019年和2026年)
  • 臍帶血/胚胎幹細胞
  • 脂肪組織來源的間質幹細胞
  • 骨髓來源的間質幹細胞
  • 其他

第9章 市場分析:各終端用戶

  • 概要
    • 市場區隔佔有率分析:各終端用戶(2019年和2026年)
  • 門診外科中心
  • 醫院
  • 其他

第10章 市場分析:各地區

  • 簡介
    • 市場區隔佔有率分析:各地區(2019年和2026年)
  • 北美
    • 概要
    • 主要製造商
    • 市場規模與預測:各國
    • 市場規模與預測:各類型
    • 市場規模與預測:各最終用途
    • 市場規模與預測:各細胞來源
    • 市場規模與預測:各終端用戶
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 義大利
    • 英國
    • 法國
    • 其他
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 韓國
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第11章 供應商分析

  • Mesoblast Ltd.
    • 公司概要
    • 財務成果
    • 產品的基準
    • 策略性配合措施
  • Vericel Corporation
  • Gamida Cell
  • Stem Cells, Inc.
  • Chiesi Farmaceutici SpA
  • Osiris Therapeutics,Inc.
  • ReNeuron Group,plc。

第12章 關於ANALYSTVIEW

第13章 附錄

  • 調查手法
  • 參考文獻
  • 簡稱
  • 免責聲明
  • 諮詢方式
目錄

REPORT HIGHLIGHT

The stem cell therapy market was valued at USD XX billion by 2018, growing with XX% CAGR during the forecast period, 2020-2026

Market Dynamics

Stem cell therapy is a rapidly advancing branch of medicine that involves repair and regeneration of tissues to improve the organ function. This therapy has gained global recognition as one of the promising breakthroughs in natural healing and renewal. Stem cell therapy is used for the treatment of various life-threatening disorders such as diabetes, spinal cord injuries Parkinson's & Alzheimer's disease, cancer, heart disease, and osteoarthritis. Advancements and innovation in stem cell therapy has been trending subject in the past decade. Stem cell research also includes collecting data and using the data to benefit potential organ transplant patients.

One of the biggest applications of stem cell therapy is its use in organ transplant and tissue regeneration. According to the National Centre of Biotechnology Information (August 2017), cell therapy has been showing promising results in solid organ transplantation and is known to be safe and feasible in clinical trials. Thus, the demand for stem cell therapy is anticipated to increase in future. In addition to this, rising number for patients demanding organ transplantation support the industry growth. Based on data published in a National Stem Cell Foundation (NSCF), approximately 115,000 patients are on the waitlist for life-saving organ transplantation surgeries.

Furthermore, a transplant study led by DRI Federation center at Xiamen University in China and scientists from the Diabetes Research Institute at the Miller School showed that mesenchymal stem cells exhibits strong potential to replace a powerful anti-rejection therapeutics in transplant recipient. This study was published by the University of Miami Health System in February 2020. This benefits remains the key driver for the growth of the stem cell therapy industry. On the other side, unclear and ambiguous regulatory guidelines for stem cell research and application will pull back the industry growth to some extent.

Types Takeaway

In terms of types, the industry is segmented as autologous, and allogeneic stem cell therapy. Among these, the allogeneic stem cell therapy dominates the worldwide stem cell therapy market. The primary reason why allogeneic stem cell therapy governs this market is due to its wide range of applications and its ease of commercialization in clinical trials. An article published in 'healio.com' (December 2018) stated, that allogeneic therapy helps in reducing the risk of relapsed follicular lymphoma.

Application Takeaway

In terms of application, the stem cell therapy industry is broadly studied into CNS diseases, oncology, eye diseases¸ wound & injuries, musculoskeletal diseases, metabolic disorders, CVS and immune system disorders. Among the mentioned applications, the CNS category held the largest market share owing to the rising CNS disorders coupled with lack of effective treatment therapies. In November 2017, the article published by the Biopharma Dealmakers stated that there is a lack of successful curative therapies for the treatment of Alzheimer's, Huntington's, and Parkinson's disease. This stem cell therapy has uplifted and firmly positioned its use to replace the damaged neurons thereby offers great hope for patients with neurodegenerative disorders.

Cell Source Takeaway

Based on the cell source segment, the industry is segmented into bone marrow-derived, adipose tissue-derived mesenchymal, and cord blood/embryonic stem cells. Within this category, the adipose tissue-derived segment accounted for maximum revenue share in 2018 and is projected to grow with promising growth rate during the forecast period. With respect to the fastest-growing category, bone marrow-derived means in mesenchymal stem cell leads undoubtedly. This cell source types are essential in providing support to the differentiation and growth of primitive hemopoietic tissues within the bone marrow microenvironment.

End-Use Takeaway

Hospitals and ambulatory surgical centres are the two end-users category analysed in this report. Among which, hospitals captured significant revenue share in 2018 and is anticipated to continue its dominance over the study period. Whereas, ambulatory surgical centres will be the fastest growing category during the projection period. Availability of centres such as Advanced Ambulatory Surgery Center (AASC) that offers world-class facility to physicians to perform stem cell procedures supports the segment growth to certain extent.

Regional Takeaway

Regionally, the North America is the most developed and dominant market with regards to stem cell therapy. This can be attributed to the rising research and development activity in the U.S market. Earlier, President Clinton had signed a law that banned Federal funding in research that was associated with destroying human embryos. In March 2019, then President Mr Obama issued an order that would favor the human embryonic stem cell research. In addition to this, as per the Charlotte Lozier Institute website (February 2018), approximately USD 131 million were allocated to human embryonic stem cell research whereas, 861 million dollar was attributed to non-embryonic stem cell research. Such favourable government initiatives would in turn help this region to grow considerably and provides path-breaking discoveries in the regenerative medicine category. The Asia Pacific follows the lead and is expected to be one of the fastest-growing markets over the forecast.

Key Vendor Takeaway

The key players that dominate the market in this category are, Mesoblast Ltd., Vericel Corporation, Gamida Cell, Stem Cells, Inc., Chiesi Farmaceutici S.p.A., Osiris Therapeutics, Inc. and ReNeuron Group, plc. Osiris therapeutics announced the completion of its acquisition by a Smith and Nephew PLC. In fact, in 2015, Chiesi Pharmaceutical drug that is an advanced stem cell therapy based medicinal product which is first of its kind was approved in Europe.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2015 to 2018

Base Year - 2019

Estimated Year - 2020

Projected Year - 2026

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Government and Regional Agencies

Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

KEY PLAYERS

Mesoblast Ltd.

Vericel Corporation

Gamida Cell

Stem Cells, Inc.

Chiesi Farmaceutici S.p.A.

Osiris Therapeutics, Inc.

ReNeuron Group, plc.

MARKET, BY TYPES

Autologous Stem Cell Therapy

Allogeneic Stem Cell Therapy

MARKET, BY APPLICATION

Eye Diseases

Wound & Injuries

Central Nervous System Diseases

Cardiovascular Disorders

Metabolic Disorders

Oncology

Musculoskeletal Diseases

Immune System Disorders

MARKET, BY CELL SOURCE

Cord Blood/Embryonic Stem Cells

Adipose Tissue-derived Mesenchymal Stem Cells

Bone Marrow-derived Mesenchymal Stem Cells

Other Cell Sources

MARKET, BY END-USE

Ambulatory Surgical Centers

Hospitals

Others

MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. STEM CELL THERAPY MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Type
    • 2.1.2. Market Snippet by End Use
    • 2.1.3. Market Snippet by Cell Source
    • 2.1.4. Market Snippet by End Use
    • 2.1.5. Market Snippet by Region
  • 2.2. Competitive Insights

3. STEM CELL THERAPY KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. STEM CELL THERAPY INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. STEM CELL THERAPY MARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. STEM CELL THERAPY MARKET - BY TYPE

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Type, 2019 & 2026 (%)
  • 6.2. Autologous Stem Cell Therapy
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.3. Allogeneic Stem Cell Therapy
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7. STEM CELL THERAPY MARKET - BY END USE

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By End Use, 2019 & 2026 (%)
  • 7.2. Eye Diseases
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.3. Wound & Injuries
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.4. Central Nervous System Diseases
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.5. Cardiovascular Disorders
    • 7.5.1. Overview
    • 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.6. Metabolic Disorders
    • 7.6.1. Overview
    • 7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.7. Oncology
    • 7.7.1. Overview
    • 7.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.8. Musculoskeletal Diseases
    • 7.8.1. Overview
    • 7.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.9. Immune System Disorders
    • 7.9.1. Overview
    • 7.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8. STEM CELL THERAPY MARKET - BY CELL SOURCE

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Cell Source, 2019 & 2026 (%)
  • 8.2. Cord Blood/Embryonic Stem Cells
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.3. Adipose Tissue-derived Mesenchymal Stem Cells
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.4. Bone Marrow-derived Mesenchymal Stem Cells
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.5. Other Cell Sources
    • 8.5.1. Overview
    • 8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9. STEM CELL THERAPY MARKET - BY END USE

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2019 & 2026 (%)
  • 9.2. Ambulatory Surgical Centres
    • 9.2.1. Overview
    • 9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.3. Hospitals
    • 9.3.1. Overview
    • 9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.4. Others
    • 9.4.1. Overview
    • 9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

10. STEM CELL THERAPY MARKET- BY GEOGRAPHY

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Cell Source, 2015 - 2026 (US$ Million)
    • 10.2.7. North America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.2.8. U.S.
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.2.9. Canada
      • 10.2.9.1. Overview
      • 10.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Cell Source, 2015 - 2026 (US$ Million)
    • 10.3.7. Europe Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.3.8. Germany
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.10. United Kingdom
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.11. France
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.12. Rest of Europe
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Cell Source, 2015 - 2026 (US$ Million)
    • 10.4.7. Asia Pacific Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.9. China
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.11. South Korea
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.12. Rest of APAC
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Cell Source, 2015 - 2026 (US$ Million)
    • 10.5.7. Latin America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.5.8. Brazil
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.9. Mexico
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.10. Argentina
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Cell Source, 2015 - 2026 (US$ Million)
    • 10.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.6.8. Saudi Arabia
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.6.9. United Arab Emirates
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

11. KEY VENDOR ANALYSIS

  • 11.1. Mesoblast Ltd.
    • 11.1.1. Company Snapshot
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Strategic Initiatives
  • 11.2. Vericel Corporation
  • 11.3. Gamida Cell
  • 11.4. Stem Cells, Inc.
  • 11.5. Chiesi Farmaceutici S.p.A.
  • 11.6. Osiris Therapeutics, Inc.
  • 11.7. ReNeuron Group, plc.

12. 360 DEGREE ANALYSTVIEW

13. APPENDIX

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Stem Cell Therapy market: Type Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Stem Cell Therapy market, by Type 2015-2026 (USD Million)
  • TABLE Stem Cell Therapy market: End Use Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by End Use
  • TABLE Global Stem Cell Therapy market, by End Use 2015-2026 (USD Million)
  • TABLE Stem Cell Therapy market: Cell Source Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Cell Source
  • TABLE Global Stem Cell Therapy market, by Cell Source 2015-2026 (USD Million)
  • TABLE Stem Cell Therapy market: End Use Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by End Use
  • TABLE Global Stem Cell Therapy market, by End Use 2015-2026 (USD Million)
  • TABLE Stem Cell Therapy market: Regional snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Stem Cell Therapy market, by Region 2015-2026 (USD Million)
  • TABLE North America Stem Cell Therapy market, by Country, 2015-2026 (USD Million)
  • TABLE North America Stem Cell Therapy market, by Type, 2015-2026 (USD Million)
  • TABLE North America Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE North America Stem Cell Therapy market, by Cell Source, 2015-2026 (USD Million)
  • TABLE North America Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE Europe Stem Cell Therapy market, by country, 2015-2026 (USD Million)
  • TABLE Europe Stem Cell Therapy market, by Type, 2015-2026 (USD Million)
  • TABLE Europe Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE Europe Stem Cell Therapy market, by Cell Source, 2015-2026 (USD Million)
  • TABLE Europe Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE Asia Pacific Stem Cell Therapy market, by country, 2015-2026 (USD Million)
  • TABLE North America Stem Cell Therapy market, by Type, 2015-2026 (USD Million)
  • TABLE Asia Pacific Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE Asia Pacific Stem Cell Therapy market, by Cell Source, 2015-2026 (USD Million)
  • TABLE Asia Pacific Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE Latin America Stem Cell Therapy market, by country, 2015-2026 (USD Million)
  • TABLE Latin America Stem Cell Therapy market, by Type, 2015-2026 (USD Million)
  • TABLE Latin America Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE Latin America Stem Cell Therapy market, by Cell Source, 2015-2026 (USD Million)
  • TABLE Latin America Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Stem Cell Therapy market, by country, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Stem Cell Therapy market, by Type, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Stem Cell Therapy market, by Cell Source, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)

List of Figures

  • FIGURE Stem Cell Therapy market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Type segment market share analysis, 2019 & 2026
  • FIGURE Type segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Autologous Stem Cell Therapy market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Allogeneic Stem Cell Therapy market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Application segment market share analysis, 2019 & 2026
  • FIGURE Application segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Eye Diseases market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Wound & Injuries market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Central Nervous System Diseases market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Cardiovascular Disorders market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Metabolic Disorders market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Oncology market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Musculoskeletal Diseases market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Immune System Disorders market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Cell Source segment market share analysis, 2019 & 2026
  • FIGURE Cell Source segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Cord Blood/Embryonic Stem Cells market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Adipose tissue-derived Mesenchymal Stem Cells market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Bone Marrow-derived Mesenchymal Stem Cells market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Other Cell Sources market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE End Use segment market share analysis, 2019 & 2026
  • FIGURE End Use segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Ambulatory Surgical Centers market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Hospitals market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Regional segment market share analysis, 2019 & 2026
  • FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE North America Stem Cell Therapy market share and leading players, 2018
  • FIGURE Europe Stem Cell Therapy market share and leading players, 2018
  • FIGURE Asia Pacific Stem Cell Therapy market share and leading players, 2018
  • FIGURE Latin America Stem Cell Therapy market share and leading players, 2018
  • FIGURE Middle East and Africa Stem Cell Therapy market share and leading players, 2018
  • FIGURE North America Stem Cell Therapy market share analysis by country, 2018
  • FIGURE U.S. Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Canada Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Europe Stem Cell Therapy market share analysis by country, 2018
  • FIGURE Germany Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Spain Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Italy Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE UK Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE France Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of the Europe Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Asia Pacific Stem Cell Therapy market share analysis by country, 2018
  • FIGURE India Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE China Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Japan Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE South Korea Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Singapore Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of APAC Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Stem Cell Therapy market share analysis by country, 2018
  • FIGURE Brazil Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Mexico Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Argentina Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of LATAM Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Stem Cell Therapy market share analysis by country, 2018
  • FIGURE Saudi Arabia Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE United Arab Emirates Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)